Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 46.69B | 34.73B | 19.61B | 12.21B | 17.75B |
Gross Profit | 35.26B | 25.15B | 10.50B | 470.21M | 5.90B |
EBITDA | 39.91B | 29.12B | 14.77B | 6.44B | 10.55B |
Net Income | 28.04B | 19.95B | 6.09B | -2.59B | 1.05B |
Balance Sheet | |||||
Total Assets | 680.00B | 563.39B | 494.24B | 494.82B | 516.49B |
Cash, Cash Equivalents and Short-Term Investments | 31.96B | 21.96B | 15.55B | 12.76B | 21.21B |
Total Debt | 323.20B | 269.10B | 240.80B | 244.94B | 262.59B |
Total Liabilities | 328.62B | 273.09B | 243.92B | 248.69B | 266.85B |
Stockholders Equity | 351.39B | 290.31B | 250.32B | 246.13B | 249.64B |
Cash Flow | |||||
Free Cash Flow | -72.80B | -33.62B | 10.86B | 11.73B | 7.30B |
Operating Cash Flow | 37.80B | 26.56B | 12.40B | 12.82B | 26.17B |
Investing Cash Flow | -111.26B | -57.52B | -1.57B | -2.75B | -20.69B |
Financing Cash Flow | 83.85B | 45.33B | -7.03B | -19.52B | -8.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥42.74B | 9.91 | 15.52% | 88.08% | 123.31% | ||
76 Outperform | €480.20B | 16.12 | 8.51% | 6.04% | 29.48% | 25.62% | |
76 Outperform | ¥142.01B | 25.36 | 552.82% | 23.82% | 7.98% | ||
73 Outperform | $391.96B | 20.48 | 6.82% | 5.12% | 25.99% | 30.74% | |
66 Neutral | £997.73M | 12.13 | -0.02% | 4.98% | 10.34% | 31.28% | |
66 Neutral | ¥567.36B | 24.41 | 6.85% | 22.58% | 8.16% |